Development and Validation of a Stability-Indicating RP-HPLC Method for Edaravone Quantification
Edaravone is used to treat motor neurone disease (MND) by slowing disease progression and prolonging survival time. Currently, it is available as an IV infusion (Radicava<sup>®</sup>, Jersey City, NJ, USA) and an oral liquid suspension (Radicava ORS<sup>®</sup>, Jersey City,...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/30/13/2866 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|